Public Profile

Nordion

Nordion, officially known as Nordion Inc., is a leading provider of medical isotopes and radiation-based technologies, headquartered in Canada. Established in 1946, the company has made significant strides in the nuclear medicine industry, particularly in the production of isotopes used for diagnostic imaging and cancer treatment. With operational facilities across North America and Europe, Nordion is renowned for its innovative solutions, including its proprietary technologies for sterilisation and radiopharmaceuticals. The company’s commitment to quality and safety has positioned it as a trusted partner in healthcare, contributing to advancements in patient care. Nordion's notable achievements include its pivotal role in the global supply of Cobalt-60, a critical isotope for cancer therapy, solidifying its market position as a key player in the medical isotope sector.

DitchCarbon Score

How does Nordion's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

22

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

2

Industry Benchmark

Nordion's score of 22 is higher than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.

86%

Let us know if this data was useful to you

Nordion's reported carbon emissions

Nordion, headquartered in Canada, currently does not have publicly available carbon emissions data or specific reduction targets. Without concrete figures or commitments, it is challenging to assess their climate impact or initiatives. However, the company is likely aware of the growing importance of sustainability and may be exploring strategies to align with industry standards for carbon reduction. As the global focus on climate change intensifies, Nordion's future commitments and actions will be crucial in determining its role in reducing carbon emissions within its sector.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Nordion's primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Nordion is in CA, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Nordion is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Pharmaceutical Product Development, LLC

US
Research and development services (73)
Updated 4 months ago
DitchCarbon Score

REVISS Services (UK) Ltd

GB
Other business services (74)
Updated 4 months ago
DitchCarbon Score

Parexel

US
Research and development services (73)
Updated 2 days ago

GE Healthcare Limited

GB
Health and social work services (85)
Updated 4 months ago
DitchCarbon Score

Bracco Diagnostics Inc.

US
Health and social work services (85)
Updated 4 months ago
DitchCarbon Score

Bayer Pharma AG

DE
Pharmaceutical Preparation Manufacturing
Updated 12 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers